A Randomized, Double-Blind, Single-Dose Study Comparing the Biosimilarity of HOT-1010 With Bevacizumab (Avastin®) in Chinese Healthy Male Subjects

• मुख्य लेखकों: Kai Huang (लेखक), Linling Que (लेखक), Ying Ding (लेखक), Nannan Chu (लेखक), Zhenzhong Qian (लेखक), Yunfei Shi (लेखक), Wei Qin (लेखक), Zhenni Li (लेखक), Yuanxin Chen (लेखक), Xianghong Gu (लेखक), Jiakun Wang (लेखक), Lin Zhang (लेखक), Jisheng Zhang (लेखक), Xiangyang Zhu (लेखक), Yongmin Yang (लेखक), Yuan Tang (लेखक), Qing He (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Frontiers Media S.A., 2021-06-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Objective: This study was conducted to compare the pharmacokinetics, safety and immunogenicity of HOT-1010 with bevacizumab (Avastin®) in Chinese healthy male subjects.Methods: A single-center, randomized, double-blind, single-dose, parallel trial was performed in 84 Chinese healthy male subjects wh...